Icon

TEPADINA (nda208264)- (15MG/VIAL,100MG/VIAL)

THIOTEPA ADIENNE SA
15MG/VIAL,100MG/VIAL
No Yes
Expired Expired
2024-Jan-26 None
None No
TEPADINA (thiotepa) is an alkylating drug indicated:  To reduce the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (HSCT) for pediatric patients with class 3 beta-thalassemia.  For treatment of adenocarcinoma of the breast or ovary.  For controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities.  For treatment of superficial papillary carcinoma of the urinary bladder.
4 0 4
Total Other Developers 5
Drugs with Suitability No
15MG/VIAL ** ** - - -
100MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** * & **** **, ***** *, ***** *, ************* ******* ******** **** (**** ), *******, *************, ****** ******* ******, ***** (***) ***
****** ****** ****** *************** **., ***. *********** **.*-* ***** ****, ******* **-**** ************* ****** ****, *******, ******* ******, ***** (***) ***
****** ***** ********** **** ********* *********** ************ **, **********, ***** ****** *****, ******* (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.